Comparing two treatments for narrowed neck arteries
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether adding a PCSK9 inhibitor to a statin is better than a statin alone for people with mild-to-moderate narrowing of the carotid artery (the main artery in the neck). It looks at how well these treatments slow plaque buildup and prevent strokes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have mild-to-moderate narrowing (plaque) in your carotid artery, confirmed by an imaging test like an ultrasound or CT scan.
- You have not had any symptoms (like a stroke or transient ischemic attack) from the narrowing.
- You do not plan to have surgery for the narrowing in the next 6 months.
- You are able to live independently (score of 2 or less on a scale of disability).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special balloon (IVL) to treat hardened plaque in the neck arteries that supply blood to the brain. It is for people who need a stent but whose previous balloon treatment did not work well.
This trial tests whether placing a stent in the narrowed carotid artery is a good option for people who are at high risk for the standard surgery (carotid endarterectomy). If you have significant blockages in your neck arteries and certain health or anatomical factors that make surgery riskier, this study may be for you.
This trial tests whether adding a PCSK9 inhibitor to standard statin therapy can help people with narrowing in brain arteries that hasn't caused symptoms yet. The goal is to see if this combination lowers plaque and prevents future strokes.
This study looks at strategies to improve cholesterol treatment in adults whose brain arteries are narrowed and who have had symptoms. Better cholesterol management may help reduce future problems related to this condition.
This trial tests whether a cholesterol-lowering medication (PCSK9 inhibitor) can help prevent further strokes in people who have recently had a stroke or mini-stroke due to a narrowed artery in the brain. It is for adults 30 to 80 years old who meet specific health criteria.
This trial tests whether alirocumab, a cholesterol-lowering injection, can stabilize dangerous plaque buildup in neck arteries (carotid arteries) that recently caused a mini-stroke or temporary vision loss. The goal is to reduce your risk of a future stroke.
Hear when a new Carotid Artery Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.